Dean W Felsher

Title: Dean W. Felsher: Innovator in Cancer Treatment and Metabolic Research

Introduction

Dean W. Felsher is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of cancer treatment and metabolic syndrome through his innovative research and patented inventions. With a total of 5 patents, Felsher's work focuses on developing methods and compositions that target specific cancer types and metabolic conditions.

Latest Patents

Felsher's latest patents include groundbreaking inventions such as inhibitors of phospholipid synthesis and methods of use. These inhibitors target Glycerol 3-Phosphate Acyltransferase (GPAT) and are designed for the treatment of cancer, as well as conditions related to metabolic syndrome and hyperlipidemia. Another notable patent involves profiling and treatment of MYC-associated cancers with NK cells and type 1 interferon. This invention provides compositions and methods for classifying and treating MYC-driven cancers, which are dependent on the over-expression or activation of the MYC gene.

Career Highlights

Dean W. Felsher is affiliated with Leland Stanford Junior University, where he conducts his research and develops his innovative solutions. His work has garnered attention in the scientific community for its potential to improve cancer treatment outcomes and address metabolic disorders.

Collaborations

Felsher collaborates with talented individuals such as Anja Deutzmann and Yulin Li, who contribute to his research efforts and help advance the understanding of cancer biology and treatment strategies.

Conclusion

Dean W. Felsher's contributions to the fields of cancer treatment and metabolic research are noteworthy. His innovative patents and collaborative efforts continue to pave the way for advancements in medical science.